Disialosyl globopentaosylceramide (DSGb5) is a ganglioside originally isolated from renal cell carcinoma (RCC) tissue that has been associated with RCC metastasis. However, in prostate cancer, the ...
NEW YORK and RESEARCH TRIANGLE PARK, N.C., May 13, 2021 (GLOBE NEWSWIRE) -- Sio Gene Therapies Inc. (NASDAQ: SIOX), a clinical-stage company focused on developing gene therapies to radically transform ...
Phase II, Randomized, Double-Blind Study of Two Dose Levels of Arzoxifene in Patients With Locally Advanced or Metastatic Breast Cancer Purpose: A heterophilic ganglioside cancer vaccine was developed ...
Researchers help the brain make GM1 ganglioside, a protective substance that is diminished in the brains of Parkinson's patients. Although a number of treatments exist to alleviate the symptoms of ...
Neoadjuvant administration of radiation therapy and intratumoral autologous dendritic cells in patients with localized high-risk soft tissue sarcomas. This is an ASCO Meeting Abstract from the 2014 ...
The discovery supports GM1 ganglioside as a potential target for Parkinson's therapy. Parkinson's disease often begins with small tremors. Over time symptoms worsen. Tremors become shakes and ...
- GM1 ganglioside in CSF reduced in 4 out of 5 children treated with the lowest dose at 6 months follow-up- Direct evidence of biochemical effect in the CNS suggests intravenous gene therapy may ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results